Skip to main content

Table 4 Multi-drug resistance profile of A. baumannii and P. aeruginosa isolates from patients clinically presumptive for nosocomial infection at FHRH, 2018 (n = 20)

From: Multi-drug resistance of blood stream, urinary tract and surgical site nosocomial infections of Acinetobacter baumannii and Pseudomonas aeruginosa among patients hospitalized at Felegehiwot referral hospital, Northwest Ethiopia: a cross-sectional study

Bacterial isolateAntibiogram ProfileAntibiotic ClassFrequency
N (%)
Over all, MDR
A. baumannii (n = 9)(AMP,AMC,CAZ,PIP,CIP,CN,SXT,MEM)63 (33.3) 
(AMP,AMC,CAZ,PIP,CN,SXT)42 (22.2) 
(AMP,AMC,CAZ,PIP,CIP,CN)41 (11.1) 
(AMP,AMC,PIP,CN,SXT)32 (22.2) 
(AMP,CAZ,PIP,SXT)31 (11.1) 
 9 (100)
P. aeruginosa (n = 11)(AMP,AMC,CAZ,PIP,CIP,CN,SXT,MEM)64 (36.4) 
(AMP,AMC,PIP,CN,SXT)32 (18.2) 
(AMP,AMC,CAZ,PIP,SXT)34 (36.4) 
 11 (100)
  1. Key: AMP: Ampicillin, AMC: Amoxicillin-clavulanic acid, PIP: Piperacillin, CAZ: Ceftazidime, CIP: Ciprofloxacin, CN: Gentamicin, MEM: Meropenem and SXT: Sulphamethoxazole- Trimethoprim, R3,4,6,: resistance to 3,4,6 antibiotic drug classes